Smiths Group has a total of 7595 patents globally, out of which 3732 have been granted. Of these 7595 patents, more than 33% patents are active. The United States of America is where Smiths Group has filed the maximum number of patents, followed by the United Kingdom and Europe. Parallelly, the United Kingdom seems to be the main focused R&D centre and also is the origin country of Smiths Group.
Smiths Group was founded in the year 1851. Smiths Group offers goods and services for the markets for medical devices, energy, communications, and threat and contraband detection.
Do read about some of the most popular patents of Smiths Group which have been covered by us in this article and also you can find Smiths Group patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Smiths Group patent portfolio.
How many patents does the founder and the CEO of Smiths Group have?
The founder Samuel Smith and CEO Paul Keel have 0 patents
How many patents does Smiths Group have?
Smiths Group has a total of 7595 patents globally. These patents belong to 2461 unique patent families. Out of 7595 patents, 2561 patents are active.
How Many Patents did Smiths Group File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Smiths Group Applications Filed | Smiths Group Patents Granted |
2023 | 13 | 51 |
2022 | 108 | 147 |
2021 | 194 | 196 |
2020 | 268 | 204 |
2019 | 216 | 191 |
2018 | 277 | 232 |
2017 | 230 | 178 |
2016 | 336 | 191 |
2015 | 385 | 179 |
2014 | 473 | 217 |
2013 | 366 | 205 |
2012 | 294 | 229 |
2011 | 340 | 160 |
How many Smiths Group patents are Alive/Dead?
How Many Patents did Smiths Group File in Different Countries?
Countries in which Smiths Group Filed Patents
Country | Patent |
United States Of America | 1325 |
United Kingdom | 931 |
Europe | 891 |
Germany | 552 |
China | 515 |
Japan | 453 |
Canada | 417 |
Australia | 327 |
Korea (South) | 172 |
Mexico | 150 |
India | 140 |
Austria | 131 |
Spain | 92 |
Russia | 85 |
Brazil | 74 |
Hong Kong (S.A.R.) | 65 |
Taiwan | 58 |
Israel | 47 |
France | 42 |
Poland | 38 |
New Zealand | 31 |
South Africa | 31 |
Italy | 29 |
Singapore | 26 |
Denmark | 25 |
Norway | 18 |
Chile | 14 |
Finland | 13 |
Argentina | 12 |
Netherlands | 7 |
Malaysia | 7 |
Portugal | 6 |
Turkey | 6 |
Indonesia | 6 |
Gulf Cooperation Council | 5 |
Sweden | 4 |
Ireland | 4 |
Switzerland | 3 |
Slovenia | 3 |
Croatia | 2 |
Serbia | 2 |
Yugoslavia/Serbia and Montenegro | 2 |
United Arab Emirates | 2 |
Hungary | 1 |
Thailand | 1 |
Saudi Arabia | 1 |
Eurasia | 1 |
Colombia | 1 |
Ecuador | 1 |
Belgium | 1 |
Peru | 1 |
Slovakia | 1 |
Czech Republic | 1 |
Lithuania | 1 |
Where are Research Centres of Smiths Group Patents Located?
10 Best Smiths Group Patents
US6744350B2 is the most popular patent in the Smiths Group portfolio. It has received 432 citations so far from companies like Abbott, M2 Medical Group Holdings and Asante Solutions.
Below is the list of 10 most cited patents of Smiths Group:
Publication Number | Citation Count |
US6744350B2 | 432 |
US7699807B2 | 414 |
US6652486B2 | 381 |
US7442186B2 | 344 |
US7572285B2 | 328 |
US6627154B1 | 294 |
US7347836B2 | 249 |
US6985779B2 | 242 |
US20090099866A1 | 237 |
US6597760B2 | 213 |
How many inventions of other companies were rejected due to Smiths Group patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Smiths Group invention. They couldn’t because Smiths Group had protected those before them.
Examiners at the USPTO referred 505 Smiths Group patents in 2919 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Smiths Group patent portfolio are Becton Dickinson, Roche Diabetes and Covidien.
List of the Companies whose Patents were rejected citing Smiths Group –
Company | Number of Patent Applications that faced Rejection Citing Smiths Group Patents | Number of Rejections (102 & 103) |
Becton Dickinson | 48 | 149 |
Roche Diabetes | 28 | 71 |
Covidien | 20 | 45 |
Resmed | 19 | 36 |
Abbott | 17 | 53 |
B Braun Melsungen | 16 | 31 |
Carefusion 303 | 14 | 35 |
Trudell Medical International | 13 | 22 |
Medtronic Minimed | 12 | 30 |
General Electric | 12 | 22 |
Count of 102 and 103 Type Rejections based on Smiths Group Patents
Top Smiths Group Patents used in Rejecting Most Patent Applications
Patent Number | Count of Rejected Applications |
US7922696B2 | 19 |
US7499739B2 | 18 |
US8192402B2 | 16 |
US20090177769A1 | 16 |
US7731691B2 | 14 |
US6744350B2 | 13 |
US6883364B2 | 13 |
US7033338B2 | 13 |
US7486977B2 | 12 |
US8995517B2 | 12 |
US6652486B2 | 12 |
US8694331B2 | 11 |
US8504179B2 | 11 |
US20080172031A1 | 11 |
US7486693B2 | 11 |
What are Smiths Group key innovation segments?
What Technologies are Covered by Smiths Group?
The chart below distributes patents filed by Smiths Group